The title 'Registered Nurse' (also known in the state of Victoria as a 'Division 1 Nurse') is granted to a Nurse who has successfully completed a board approved course in the field of nursing, as outlined by education and registration standards defined by the NMBA.
LINZESSÂ® (linaclotide) is a prescription medication used in adults to treat irritable bowel syndrome with constipation (IBSâC) and chronic idiopathic constipation (CIC). Idiopathic means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children.
LINZESS is contraindicated in patients less than 6 years of age. In nonclinical studies in neonatal mice, administration of a single, clinically relevant adult oral dose of linaclotide caused deaths due to dehydration. Use of LINZESS should be avoided in patients 6 years to less than 18 years of age. The safety and effectiveness of LINZESS have not been established in patients less than 18 years of age. LINZESS is contraindicated in patients less than 6 years of age due to the risk of serious dehydration.